Krystal Biotech buy Jefferies Financial Group Inc.
Start price
17.02.26
/
50%
€245.60
Target price
17.02.27
-
Performance (%)
14.13%
Price
06.08.26
€280.30
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ currently has a performance of 14.13%. This prediction currently runs until 17.02.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -11.952% | -11.952% |
| iShares Core DAX® | 1,84 % | 1,39 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % |
| iShares S&P 500 | 3,70 % | 1,58 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€166.55
05.03.25
05.03.25
€228.54
05.03.26
05.03.26
34.31%
06.03.26
06.03.26
